Enveda Biosciences Company
Platform uses metabolomics and machine learning to explore the chemistry of the natural world for novel drug discovery.
Investors
Connections from
Founded Date:
2019
Industry:
Early Drug Development
Total Funding:
$230M
Headquarters:
USA